Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 3
1982 4
1983 1
1984 11
1985 7
1986 18
1987 25
1988 15
1989 20
1990 18
1991 15
1992 17
1993 7
1994 14
1995 11
1996 4
1997 2
1998 1
1999 2
2000 4
2001 1
2002 1
2003 5
2004 2
2005 2
2006 4
2007 4
2008 2
2009 5
2010 3
2011 4
2012 7
2013 4
2014 3
2015 1
2016 5
2017 12
2018 10
2019 2
2020 1
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

270 results
Results by year
Filters applied: . Clear all
Page 1
New drug therapies for multiple sclerosis.
Mangas A, Coveñas R, Geffard M. Mangas A, et al. Among authors: geffard m. Curr Opin Neurol. 2010 Jun;23(3):287-92. doi: 10.1097/WCO.0b013e32833960f6. Curr Opin Neurol. 2010. PMID: 20414110 Review.
GEMSP: a new therapeutic approach to multiple sclerosis.
Geffard M, Duleu S, Bessede A, Vigier V, Bodet D, Mangas A, Covenas R. Geffard M, et al. Cent Nerv Syst Agents Med Chem. 2012 Sep;12(3):173-81. doi: 10.2174/187152412802430110. Cent Nerv Syst Agents Med Chem. 2012. PMID: 22533511 Review.
Frontiers in vitamin research: new antibodies, new data.
Coveñas R, Mangas A, Bodet D, Duleu S, Marcos P, Karakas B, Geffard M. Coveñas R, et al. Among authors: geffard m. ScientificWorldJournal. 2011 Jun 9;11:1226-42. doi: 10.1100/tsw.2011.115. ScientificWorldJournal. 2011. PMID: 21666992 Free PMC article. Review.
A new drug candidate (GEMSP) for multiple sclerosis.
Mangas A, Coveñas R, Bodet D, Duleu S, Geffard M. Mangas A, et al. Among authors: geffard m. Curr Med Chem. 2009;16(25):3203-14. doi: 10.2174/092986709788803259. Epub 2009 Sep 1. Curr Med Chem. 2009. PMID: 19548873 Review.
(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors.
Maes M, Leonard B, Fernandez A, Kubera M, Nowak G, Veerhuis R, Gardner A, Ruckoanich P, Geffard M, Altamura C, Galecki P, Berk M. Maes M, et al. Among authors: geffard m. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):659-63. doi: 10.1016/j.pnpbp.2011.02.019. Epub 2011 Mar 2. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21376099 No abstract available.
Lauryl-poly-L-lysine: A New Antimicrobial Agent?
Vidal L, Thuault V, Mangas A, Coveñas R, Thienpont A, Geffard M. Vidal L, et al. Among authors: geffard m. J Amino Acids. 2014;2014:672367. doi: 10.1155/2014/672367. Epub 2014 Feb 23. J Amino Acids. 2014. PMID: 24660058 Free PMC article.
Correction to: Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.
Maes M, Sirivichayakul S, Matsumoto AK, Maes A, Michelin AP, de Oliveira Semeão L, de Lima Pedrão JV, G Moreira E, Barbosa DS, Geffard M, Carvalho AF, Kanchanatawan B. Maes M, et al. Among authors: geffard m. Mol Neurobiol. 2022 Feb;59(2):1350. doi: 10.1007/s12035-021-02692-4. Mol Neurobiol. 2022. PMID: 35041141 No abstract available.
Antibodies to reduced glutathione.
Amara A, Coussemacq M, Geffard M. Amara A, et al. Among authors: geffard m. Brain Res. 1994 Oct 3;659(1-2):237-42. doi: 10.1016/0006-8993(94)90885-0. Brain Res. 1994. PMID: 7820668
270 results